How extent of Barrett's metaplasia influences the risk of esophageal adenocarcinoma. Issue 4 (July 2021)

• Record Type: Journal Article
• Authors: Meyer, Chase; Hejazi, Reza; Bansal, Ajay
• Is Part Of: Current opinion in gastroenterology. Volume 37:Issue 4(2021)
• Publication Date: 2021-07
• Subjects: Barrett's esophagus -- esophageal adenocarcinoma -- irregular Z line -- surveillance; Gastroenterology -- Periodicals; 616.33
• DOI: 10.1097/MOG.0000000000000743
• Languages: English
• ISSNs: 0267-1379

Abstract

Abstract : Purpose of review: This review will focus on how the extent of Barrett's metaplasia influences the risk of esophageal adenocarcinoma (EAC). More specifically, this review will discuss the concepts of long and short-segment Barrett's metaplasia and irregular Z line as they relate to EAC risk. Recent findings: The Prague classification can standardize reporting of Barrett's metaplasia. Recent literature has found significant associations between the length of Barrett's metaplasia and increased progression risk to EAC in multiple geographically distinct populations. Length of Barrett's metaplasia has been incorporated into the Progression of Barrett's esophagus (PIB) model that can predict individualized life-time risks of progression. The risk of malignant transformation appears to be very low in patients with irregular Z line. Summary: Length of Barrett's metaplasia has emerged as an important predictor that can influence the risk of EAC and should be reported using the Prague classification. The PIB model, if further validated, could help a practicing gastroenterologist to inform patients with Barrett's metaplasia about their personal risk of progression to tailor surveillance intervals. Current guidelines do not recommend surveillance in patients with irregular Z line, but careful examination is recommended.